Predictions
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.10
18.08.20
18.08.20
-
04.11.21
04.11.21
-12.10%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.10
18.08.20
18.08.20
-
04.11.21
04.11.21
-12.10%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.10
18.08.20
18.08.20
-
04.11.21
04.11.21
-12.10%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Macy's Inc.
Start price
Target price
Perf. (%)
€5.74
18.08.20
18.08.20
-
26.10.20
26.10.20
2.60%
26.10.20
26.10.20
Business model of the past or high risk
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€150.60
18.08.20
18.08.20
€210.00
04.11.21
04.11.21
29.61%
22.01.21
22.01.21
Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
Dollar General Corp.
Start price
Target price
Perf. (%)
€169.04
17.08.20
17.08.20
-
22.10.20
22.10.20
7.64%
22.10.20
22.10.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Vonovia SE
Start price
Target price
Perf. (%)
€58.52
17.08.20
17.08.20
€58.00
04.11.21
04.11.21
-8.20%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
CME Group Inc.
Start price
Target price
Perf. (%)
€147.24
17.08.20
17.08.20
-
18.10.20
18.10.20
-3.74%
18.10.20
18.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
CME Group Inc.
Start price
Target price
Perf. (%)
€147.24
17.08.20
17.08.20
-
18.10.20
18.10.20
-3.74%
18.10.20
18.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
Union Pacific Corp.
Start price
Target price
Perf. (%)
€163.20
17.08.20
17.08.20
-
18.10.20
18.10.20
10.37%
18.10.20
18.10.20
ROE higher than 10% per year
High valuation
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Intel Corp.
Start price
Target price
Perf. (%)
€41.49
17.08.20
17.08.20
-
04.11.21
04.11.21
9.53%
17.08.21
17.08.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€41.49
17.08.20
17.08.20
-
04.11.21
04.11.21
9.53%
17.08.21
17.08.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€41.49
17.08.20
17.08.20
-
04.11.21
04.11.21
9.53%
17.08.21
17.08.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€41.49
17.08.20
17.08.20
-
04.11.21
04.11.21
9.53%
17.08.21
17.08.21
Could be worthwhile Investment >10% per year
ConocoPhillips
Start price
Target price
Perf. (%)
€34.33
17.08.20
17.08.20
-
21.10.20
21.10.20
-22.85%
21.10.20
21.10.20
Capable Management
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Metlife Inc.
Start price
Target price
Perf. (%)
€33.60
17.08.20
17.08.20
-
17.10.20
17.10.20
0.00%
17.10.20
17.10.20
EBIT growth >5% per year expected
High dividend yield expected
Revenue decline/stagnation expected
TJX Companies Inc.
Start price
Target price
Perf. (%)
€49.32
16.08.20
16.08.20
-
24.10.20
24.10.20
-4.81%
24.10.20
24.10.20
Revenue growth >5% per year expected
Probably not worthwhile Investment
Siemens AG
Start price
Target price
Perf. (%)
€115.58
16.08.20
16.08.20
-
04.11.21
04.11.21
25.64%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Medium risks for its business
Siemens AG
Start price
Target price
Perf. (%)
€115.58
16.08.20
16.08.20
-
04.11.21
04.11.21
25.64%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Medium risks for its business
Advance Auto Parts Inc.
Start price
Target price
Perf. (%)
€133.00
16.08.20
16.08.20
-
31.10.20
31.10.20
-5.26%
31.10.20
31.10.20
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Below average Management